These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [The value of a rapidly acting anticoagulant in cardiovascular diseases]. SEISLER KH Ther Ggw; 1959 Jun; 98(6):281-5. PubMed ID: 13676099 [No Abstract] [Full Text] [Related]
26. [Critical comments on therapy of hepatitis with lipotropic substances]. STAHL I Arztl Wochensch; 1952 Oct; 7(43):1010-4. PubMed ID: 12996377 [No Abstract] [Full Text] [Related]
27. Fiction and facts about lipotropic medication in atherosclerosis. POLLACK OJ Del State Med J; 1952 Jun; 24(6):157-9. PubMed ID: 14936454 [No Abstract] [Full Text] [Related]
28. [Use of lipotropic factors in the therapy of chronic cardiac insufficiency]. SANDRI A Arcisp S Anna Ferrara; 1950; 3(4):371-97. PubMed ID: 24541137 [No Abstract] [Full Text] [Related]
29. [Intermediate metabolism of choline and other lipotropic factors]. Stagni F Ann Sanita Pubblica; 1969; 30(1):105-9. PubMed ID: 4102897 [No Abstract] [Full Text] [Related]
30. [The mechanism of action of choline as lipotropic substance]. PASARGIKLIAN M; BALDINI M Atti Accad Fisiocrit Siena Med Fis; 1950; 18(1):22-7. PubMed ID: 15414165 [No Abstract] [Full Text] [Related]
31. [The biological importance of choline. Review. Choline in the diet. Lipotropic effect of proteins and amino acids. II]. Stagni F Ann Sanita Pubblica; 1968; 29(6):1549-54. PubMed ID: 4193996 [No Abstract] [Full Text] [Related]
32. [The biological importance of choline. Review. VI. The problem of other lipotropic factors besides choline in the pancreas and pancreatic juice]. Stagni F Ann Sanita Pubblica; 1969; 30(4):571-3. PubMed ID: 4192694 [No Abstract] [Full Text] [Related]
33. [Lipotropic action of a iodine derivative and of choline]. LOZANO J; GALLEGO N Med Esp; 1952 Aug; 28(161):99-104. PubMed ID: 13001729 [No Abstract] [Full Text] [Related]
34. Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease? Kleschyov AL; Sen' VD Future Med Chem; 2013 Mar; 5(4):385-8. PubMed ID: 23495686 [No Abstract] [Full Text] [Related]
35. [The initial experience of using fraxiparin in extracorporeal detoxication in clinical cardiology]. Sirenko IuN; Sychev OS; Reĭko MN; Shchupak MB; Sidorenko PI Klin Khir (1962); 1994; (12):23-5. PubMed ID: 9173120 [TBL] [Abstract][Full Text] [Related]
36. [Importance of the lipotropic factors (choline) on the behavior of lipids in heterotopic ossification]. CATALANO G Minerva Chir; 1953 Feb; 8(3):99-104. PubMed ID: 13063178 [No Abstract] [Full Text] [Related]
37. Studies on lipotropic factors. I. Choline content of the serum in normal and in patients suffering from cirrhosis of the liver. GOVINDAN KK; RADHAKRISHNA RAO MV Indian J Med Res; 1952 Oct; 40(4):505-10. PubMed ID: 13061058 [No Abstract] [Full Text] [Related]
38. [Lipotropic activity of trypsin in a choline-resistant steatosis]. PENNETTI V; ROMANO E Boll Soc Ital Biol Sper; 1952 Nov; 28(11):1832-4. PubMed ID: 13041910 [No Abstract] [Full Text] [Related]
39. [Proposals for a plan of fibrinolytic-clearing therapy of peripheral obstructive arteriopathy]. Ferliga G G Gerontol; 1967 Aug; 15(8):955-71. PubMed ID: 4181505 [No Abstract] [Full Text] [Related]
40. [The biological importance of choline. Review. IV. Vitamins of the B complex and lipotropic factors]. Stagni F Ann Sanita Pubblica; 1969; 30(2):229-33. PubMed ID: 4188988 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]